Merck & Co.
Search results
For 175 years, Pfizer has been a trusted partner in healthcare – discovering, developing, and delivering medical breakthroughs to prevent, treat, and cure some of the world’s most vexing conditions and diseases.
Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology.
We are constantly working towards bringing breakthroughs that change patients’ lives, faster and easier than ever before. This center is a part of a network of 12 global centers set up worldwide, it is the first and only one at present set up by Pfizer in Asia.
Headquartered in Mumbai, Pfizer Products India Pvt Ltd (PPIPL) is a wholly owned subsidiary of Pfizer Inc. The company is engaged in importing, trading, marketing and distribution of pharmaceuticals products across key therapy areas such as Oncology, Rare Diseases and Anti-infectives.
Pfizer works to translate advanced science and technologies into therapies that matter the most. Find out more
Vaccines work by preparing the body’s immune system with a defense against the pathogen. The virus or bacterium is recognized, neutralized, and destroyed, often before it can spread. Our Vaccine Research and Development scientists are working to extend the benefits of vaccines into new areas.
Pfizer is one of the world’s leading pharmaceutical companies, founded more than 170 years ago. We specialise with expert therapy in 6 product-portfolios of- Vaccines, Oncology, Internal Medicine, Rare Diseases, Inflammation and Immunology, and Hospitals.
Pfizer Inc. and BioNTech SE announced today they have begun an evaluation of the safety and immunogenicity of a third dose of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) to understand the effect of a booster on immunity against COVID-19 caused by the circulating and potential newly emerging SARS-CoV-2 variants.
Get all the information on Pfizer with historic price charts for NSE / BSE. Experts & Broker view also get the Pfizer Ltd. buy/sell tips detailed news, announcements, Forecasts, Analysts ...
Aug 23, 2021 · The Food and Drug Administration on Monday granted full approval to Pfizer-BioNTech’s coronavirus vaccine for people 16 and older, making it the first to move beyond emergency-use status in...
